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Computation of Protein-Ligand Binding Free Energies using 
Quantum Mechanical Bespoke Force Fields 
Daniel J. Cole,*a Israel Cabeza de Vaca b and William L. Jorgensen b 
A quantum mechanical bespoke molecular mechanics force field is 
derived for the L99A mutant of T4 lysozyme and used to compute 
absolute binding free energies of six benzene analogs to the 
protein. Promising agreement between theory and experiment 
highlights the potential for future use of system-specific force fields 
in computer-aided drug design.
Alchemical free energy methods are a widely used 
computational tool for predicting binding affinities of 
biomolecular complexes.1-3 The ability to accurately predict 
protein-ligand binding free energy would have a profound 
impact on our ability to guide molecular design and prioritize 
compounds in early stage drug discovery.4-7 One of the many 
computational techniques developed for such a purpose is free 
energy perturbation (FEP) theory. FEP, in combination with 
molecular dynamics (MD) or Monte Carlo (MC) sampling of 
biomolecular conformation, provides a rigorous means to 
compute protein-ligand binding free energy. Its accuracy is 
limited, in practice, only by the accuracy of the underlying 
molecular mechanics (MM) force field used to compute 
atomistic interactions and dynamics, and by finite sampling that 
can limit the exploration of conformational space.
Biomolecular MM force fields, such as OPLS, AMBER, 
CHARMM and GROMOS, have been under development for ca. 
40 years. In these force fields, covalent bonding is described 
using harmonic bond stretching and angle bending 
components, in conjunction with anharmonic torsion rotation 
terms, while the non-bonded component is a sum of 
electrostatic interactions between atom-centered point 
charges and Lennard-Jones interactions. Strategies vary, but in 
general the parameters used to describe these interatomic 
potentials are fit to reproduce the quantum mechanical (QM) 
and experimental properties of small organic molecules.8-11 This 
combination of a physically motivated functional form, 
alongside very careful parameterization, means that MM force 
fields generally describe biomolecular dynamics and 
interactions well.12,13
However, there is also potential room for improvement. 
Implicit in the described parameterization process is the 
assumption of transferability. That is, parameters that are fit to 
reproduce QM or experimental properties of small molecules 
are assumed to also be optimal for describing macromolecular 
dynamics. While methods are under development for rigorously 
correcting computed MM free energies by processing 
snapshots using hybrid QM/MM,14-16 or even large-scale QM,17 
these approaches require many evaluations of the QM energy 
and it is as yet unclear how accurate they are when applied to 
protein-ligand binding.
An alternative to the use of transferable MM force fields for 
sampling molecular conformational space is the derivation of a 
system-specific, or bespoke, force field directly for the molecule 
under study, thus avoiding the parameter transferability 
assumption. Several different approaches to system-specific 
force field derivation have been developed.18-20 All of these 
have in common the use of QM for parameter derivation, since 
experimental measurements are unlikely to be available for any 
but the simplest organic molecules. However, the applicability 
of these methods is limited to small system sizes (e.g. <100 
atoms), either by the expense of the QM calculation or the 
sheer number of parameters required to describe biomolecular 
dynamics.
To address these issues, the QUantum mechanical BEspoke 
(QUBE) force field for protein modelling has recently been 
developed, as described in detail elsewhere.21,22 In contrast to 
standard biomolecular force fields, non-bonded parameters are 
derived specifically for the system under study. This is made 
possible by advances in linear-scaling QM software, which 
enable the computation of the ground state electron density of 
systems comprising many thousands of atoms.23 In QUBE, the 
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total electron density is partitioned into atom-centered 
basins24,25 and used to derive atoms-in-molecule charge and 
Lennard-Jones parameters.26 In contrast, local covalent 
interactions (bond, angle and torsion components) are treated 
in a similar manner to transferable force fields. Bond and angle 
parameters are derived from the QM Hessian matrices of small, 
model dipeptides using the so-called modified Seminario 
method.27 To complete the first version of the QUBE protein 
force field, torsion parameters have been extensively re-fit for 
compatibility with the rest of the QUBE parameter set, using 
QM dihedral scans.22 Bonded parameters are read from a library 
and assumed to be transferable. The QUBE method has been 
validated and shown to be similar in accuracy to widely-used 
transferable force fields by comparing the condensed phase 
properties of a database of small, organic molecules with 
experiment, and by comparing computed protein dynamics 
with experimental NMR observables.21,22 However, QUBE has 
not been used before now to predict protein-ligand binding 
affinity and it remains to be seen how accurate it is for potential 
use in computer-aided drug design applications.
One problem with the use of protein-ligand binding free 
energies for force field validation is that it is difficult to separate 
possible force field inaccuracy from the aforementioned 
limitations in conformational sampling, which can lead to 
incorrect predicted binding poses if not treated carefully. To get 
around this problem, in this paper, we investigate the binding 
of several small, rigid benzene derivatives to an engineered 
binding site of the T4-lysozyme L99A protein (hereinafter 
referred to as lysozyme) using the QUBE force field. This is a 
relatively simple binding site, and there is a wide range of 
experimental structural and calorimetric data available.28,29 For 
these reasons, lysozyme has been recommended as a potential 
community benchmark test system,3 and it is commonly used to 
validate new computational methodologies.30-32 In particular, 
standard MM force fields yield  reasonably accurate free 
energies,33-35 though even for this relatively simple system, 
larger ligands can present challenging sampling requirements.36
The lysozyme binding site has recently been used to develop 
and validate new computational algorithms for exploring 
protein-ligand conformational space with the MCPRO 
software,37 with emphasis on improved backbone and side 
chain Monte Carlo moves.38 Alongside the recently 
implemented replica exchange with solute tempering (REST) 
method,39-44 which is employed here to enhance sampling in 
localized regions of the system, we now have the ability to 
employ extensive sampling of protein-ligand binding modes and 
hence focus our efforts on validation and improvement of the 
QUBE force field.
The QUBE force field is designed specifically for the system 
under study through post-processing of the QM electron 
density, and due to its implementation in linear-scaling QM 
software it may be applied to a range of proteins comprising 
many thousands of atoms. Here, the entire lysozyme protein 
(164 residues, 2628 atoms) was parameterized using the QUBE 
force field (see the ESI for system preparation and methods). 
The QM electron density was obtained using the ONETEP linear-
scaling density functional theory software,45 and atoms-in-
molecule analysis24,25 was performed to extract atomic charges 
and Lennard-Jones parameters from the partitioned atomic 
electron densities.26 Figure 1(a) compares the derived QUBE 
charges with widely-used OPLS force field parameters. In line 
with previous studies,26 we observe a strong correlation 
between QUBE and OPLS charges. This is despite the very 
different parameterization strategies employed. While QUBE 
charges are derived directly from the QM electron density, OPLS 
charges have been very carefully fit to reproduce the 
experimental condensed phase properties of small organic 
molecules.8 Also noteworthy is the spread of charges along the 
y-axis, which demonstrates the ability of QUBE charges to adapt 
to their chemical and electrostatic environment, which is 
expected to improve the point charge description of the 
electrostatic potential at the protein surface.
Figure 1(b) displays the correlation between summed QUBE 
and OPLS C6 parameters per residue, which provides a measure 
of the interatomic van der Waals interaction, a fundamental 
driving force behind protein folding and dynamics (see the ESI 
for a full description). Again, strong correlation is observed 
between the two parameterization strategies. However, the 
QUBE van der Waals coefficients are approximately 1.5x lower 
than in the OPLS force field. This is in very good agreement with 
previous comparisons between QM-derived C6 parameters and 
standard force fields, and does suggest that force field 
parameters have been elevated to effectively account for 
higher-order QM interactions absent in the simple force field 
functional form.46 Nevertheless, experimental condensed 
phase properties of organic molecules are reproduced to a high 
degree of accuracy using the current QUBE model,21 and so it is 
informative to ascertain its accuracy in describing protein-
ligand binding.
Protein dynamics using the QUBE force field are extensively 
validated elsewhere,22 however protein-ligand binding has not 
been assessed before. The software tool QUBEKit21 has been 
employed to parameterize six small, rigid benzene analogs, and 
extensive MC sampling of protein-ligand conformational space 
has been performed using the MCPRO software and the REST 
enhanced sampling algorithm (see the ESI). Figure 2(a) shows an 
overlay of the simulated lysozyme-benzene complex with the 
experimental crystal structure (PDB: 181L). The agreement 
between the two structures is promising. Notably, the V111 side 
chain is known to undergo reorientation upon binding larger 
benzene derivatives (in particular, o-xylene and p-xylene from 
the set studied here).29 Figure 2(b) indicates that this 
reorientation has been captured in the case of o-xylene. Since 
all input structures used here were based on the benzene-
bound form, this is encouraging both for the QUBE force field 
description of the complex and the enhanced MC sampling 
employed (see the ESI). To study this reorientation in more 
detail, Figure 3 shows the distribution of side chain dihedral 
angles sampled during the MC simulations of lysozyme bound 
to o-xylene and p-xylene, and in its apo form. The latter 
structures are extracted from the final window of the free 
energy calculations, with the ligand fully annihilated. Bound to 
o-xylene, the V111 side chain explores three different rotamers 
with a preference for 300°. Bound to p-xylene, the V111 side 
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chain prefers the 180° rotamer, though some exploration of the 
300° rotamer is observed. Experimentally, in both cases, the 
300° rotamer is expected, though populations of alternative 
conformations may not be visible in the X-ray electron density. 
In all cases, in the unbound form, V111 has a strong preference 
for the 180° rotamer, in good agreement with experiment.29 For 
the other four ligands studied here (data not shown), the 180° 
rotamer is preferred, and only indene shows any significant 
sampling of the 300° rotamer. Thus, simulated protein-ligand 
conformations are in broad agreement with experimental 
observations. However, a much more reliable indicator of force 
field accuracy is the use of free energy calculations to compute 
protein-ligand binding affinity.
Absolute binding free energies of benzene, and five further 
derivatives, to lysozyme were computed using the QUBE force 
field, and compared with experiment (Table 1). Overall, the 
mean unsigned error (MUE) of 0.85 kcal/mol is extremely 
competitive with established, widely-used transferable force 
fields. For comparison, the MUEs obtained for the same dataset 
in recent literature studies are 1.26 kcal/mol using the OPLS 
force field,38 and 2.09 kcal/mol using the AMBER/AM1-BCC 
force field and the confine-release protocol (Table S1).33 In the 
current study, we did not observe any significant outliers from 
experiment. Indole, indene and benzofuran each have UE > 1 
kcal/mol. Inaccuracy in the description of indole binding may be 
explained by the neglect of off-site charges to model anisotropic 
electron density. We have shown previously that such effects 
are important in the accurate description of interactions of the 
sulfur atom in the neighboring binding site residue M102.26 The 
difference between the computed binding free energies of 
indene and benzofuran are more difficult to explain, and may 
reflect inaccuracy in this first-generation protein force field. A 
previous study examining small molecule properties has shown 
that computed hydration free energies of small non-polar 
molecules using QUBE tend to be too positive compared with 
experiment.21 Similar results are found here (Table S2), which 
may explain some of the deviations from experiment, though 
some cancellation of errors is expected in the free energy cycles 
used to compute protein-ligand binding. Indeed, the binding 
free energies of the non-polar o-xylene and p-xylene are in 
particularly close agreement with experiment, which indicates 
not only that the QUBE force field is able to describe changes in 
van der Waals interactions upon moving between water and the 
protein binding site (Figure 1(b)), but also that the use of REST 
enhanced sampling is able to capture the V111 reorientation 
upon binding these larger analogs (Figure 3).
Conclusions
In summary, the quantum mechanical bespoke force field, 
QUBE, has been used to compute the absolute binding free 
energies of six benzene derivatives to the engineered L99A 
mutant of T4 lysozyme. Encouraging agreement is obtained 
between theory and experiment with a MUE of just 0.85 
kcal/mol. Known challenges regarding the reorientation of V111 
in the protein binding site have been addressed through recent 
improvements to MC configurational sampling algorithms and 
the use of a local enhanced sampling (REST) method. It is 
important to note that, since the majority of the force field 
parameters used in the current study are derived from quantum 
mechanics rather than fit to experiment, there is significant 
potential for systematic improvement of the results. For 
example, new force fields employing more accurate underlying 
quantum mechanical methods or alternative atoms-in-
molecule analysis schemes47 may be employed to compute the 
partitioned atomic electron density. More fundamentally, the 
functional form of the force field may be updated by, for 
example, including terms beyond the C6r-6 interaction (Figure 
1(b)) to describe van der Waals interactions,48,49 or altering the 
short-range repulsion term,50 or including more advanced 
torsion potentials to account for coupling between internal 
coordinates.51,52 Beyond improvement of the QUBE force field, 
we are also planning further validation of protein-ligand binding 
free energies beyond the relatively simple lysozyme model and 
extension of the applicability of the method to, for example, the 
description of metal centers in protein binding sites.53 Overall, 
however, the current study represents an encouraging first step 
toward the use of system-specific QM-derived force fields in 
molecular design and prospective drug discovery efforts.
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ΔGexp ΔGQUBE UE
benzene -5.19 -5.97 (0.2) 0.78
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Figure 1. a) Correlation between derived QUBE and OPLS atomic 
charges for the lysozyme protein. The dashed line is given by the 
equation y = x. b) Correlation between derived QUBE and OPLS C6 
parameters per residue. The dashed line is given by the equation y = 
0.66x.
Figure 2. a) Overlay of crystal structures (grey) and binding site 
residues from final snapshots of MC simulations (green) of (a) 
lysozyme-benzene (after 30 million Monte Carlo steps) and (b) 
lysozyme-o-xylene (after 80 million Monte Carlo steps) complexes. 
The residue V111 is indicated by an arrow.
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Figure 3. Sampled V111 side chain orientations in lysozyme from 
simulations of lysozyme-o-xylene and lysozyme-p-xylene. 
Experimentally, the apo protein side chain has a dihedral angle of 
180° and the holo has a dihedral angle close to 300° for both o-
xylene and p-xylene.
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